The "FDA" approves the emergency use of the antibody drug "Regeneron" to treat Corona
The US Food and Drug Administration "FDA" approved the emergency use of the antibody drug Regeneron to treat the Corona virus, which was given to President Trump, according to the FDA website and "Reuters"
The site said, the US Food and Drug Administration today issued a permit for the emergency use of antibody therapy to treat the Corona virus from Regeneron Pharmaceuticals, an experimental treatment that was presented to US President Donald Trump, and who confirmed that it helped treat him from the disease.
The "Regeneron antibody cocktail that contains an antibody produced by the company, and a second isolated from humans who have recovered from the Coronavirus, is designed so that the two antibodies search for a spike protein for the Corona virus and binds them to prevent it from entering healthy human cells."
"Clinical evidence from outpatient experiences indicates that monoclonal antibodies such as the drug REGEN-COV2 have the greatest benefit when given early after diagnosis, and in patients who have not developed their immune response or who have a high viral load," said Regenron, Inc. In the body"
The company added that it expects to have REGEN-COV2 ready for about 80,000 patients by the end of this month, about 200,000 patients by the first week of January and nearly 300,000 in total by the end of January.
The US Food and Drug Administration "FDA" confirmed that antibodies are not authorized for patients who are hospitalized because of the Corona virus or who need oxygen treatment because of the virus.
